Clever Carnivore is a technology company.
Clever Carnivore has raised $7.0M across 1 funding round.
Clever Carnivore has raised $7.0M in total across 1 funding round.
Clever Carnivore is a Chicago-based foodtech startup founded in 2021 that produces cultivated (lab-grown) meat—real beef, pork, and chicken grown from animal stem cells—identical on a cellular level to farm-raised meat but without livestock farming, antibiotics, pathogens, or animal harm.[1][2][3] It serves consumers seeking sustainable, cruelty-free protein options by blending cultivated cells (e.g., 10% in products like bratwurst, sausages, hotdogs, and meatballs) with plant-based meat to create familiar foods that reduce environmental impact like greenhouse gas emissions.[1][3][4] The company has raised $9.1M total, including a $7M seed round about a year ago, and operates at pilot scale with 500-liter bioreactors while scaling toward a 40,000-liter demo plant; it recently expanded to a new 4,179 sq ft HQ/lab in Lincoln Park.[1][2][4][5]
Clever Carnivore was co-founded in 2021 by Dr. Paul Burridge, a Northwestern University pharmacology professor and stem cell biologist specializing in low-cost cell culture media (holding relevant patents), and Dr. Virginia Rangos, a sociologist expert in social behavior and identity.[1][3][4] The idea emerged from Burridge's research in chemically defined media formulations and a drive to address meat production's environmental and ethical issues through biotechnology, akin to brewery fermentation but using animal tissue samples fed pure nutrients.[1][3] Early traction included $2.1M pre-seed funding and pilot-scale operations; pivotal moments feature a $7M seed round to expand production, hiring food scientist Russell Thomas (ex-Tyson) as Chief Product Officer for its debut bratwurst, and opening a new Chicago HQ in Lincoln Park, dubbed the "academic epicenter."[1][2][4][5]
Clever Carnivore rides the cultivated meat wave, a $20B+ potential market amid climate pressures (livestock emits ~14.5% of global GHGs) and demand for sustainable proteins without vegan compromises on taste/texture.[1][4] Timing aligns with maturing biotech: falling media costs and bioreactor scaling make profitability viable, countering hype fatigue from overfunded peers like Believer Meats or SuperMeat that faced delays.[2][4] Favorable forces include non-GMO focus for U.S./EU acceptance, U.S. regulatory progress (e.g., FDA approvals), and Chicago's foodtech hub status; it influences the ecosystem by pioneering affordable hybrids, proving shoestring R&D works, and attracting talent/investment to cellular agriculture.[1][2][4]
Clever Carnivore's pilot-to-demo scale-up positions it for commercial breakthroughs, targeting low-cost cultivated meat in consumer products like its bratwurst by leveraging optimized cells and media.[4] Trends like precision fermentation advances, hybrid meat adoption, and sustainability mandates will accelerate growth, potentially hitting profitability as costs drop below conventional meat. Its influence may expand via partnerships (e.g., food giants) and policy wins, evolving from Chicago upstart to cultivated meat leader—delivering the "21st-century burger" that makes real meat ethical and planet-friendly.[3][4]
Clever Carnivore has raised $7.0M in total across 1 funding round.
Clever Carnivore's investors include Leaps by Bayer, Lever VC, Sacramento Angels.
Clever Carnivore has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Seed in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2023 | $7.0M Seed | Leaps by Bayer, Lever VC, Sacramento Angels |